We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr. Yue Liu, CEO and co-founder of Ab Studio Inc., was a senior scientist working at Elan Pharmaceutical/Prothena Bioscience's antibody engineering group. She has supported four clinical programs on antibody optimization, leading clinical candidate selection and designed 12 humanized antibodies. These therapeutic antibodies were developed to target multiple diseases such as Alzheimer’s disease, Parkinson’s disease, cancer, inflammation, diabetes and rare diseases. Dr. Liu also served as the leader of Prothena’s innovation club to organize discussions on new research proposals, new technology platforms and new journal publications. Before joining Elan, Dr. Liu had been working at UCSF, where she identified a novel cancer target and contributed to an ADC program which was licensed by Fortis. Dr. Yue Liu received her Ph.D. from Universite de Sherbrooke, Canada, Master’s degree from Medical School of Suzhou University, China and Bachelor’s degree from Nanjing University, China.
This speaker's sessions: